UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Link zum Volltext

Verfügbarkeit prüfen

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Blood, 2013-06, Vol.121 (26), p.5113-5123

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Clinical cancer research, 2017-07, Vol.23 (14), p.3499-3509

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Molecular therapy, 2013-11, Vol.21 (11), p.2113-2121

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Blood, 2014-06, Vol.123 (25), p.3895-3905

2014

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Blood, 2009-11, Vol.114 (19), p.4283-4292

2009

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1415-1425

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy

The Journal of infectious diseases, 2017-09, Vol.216 (6), p.678-687

2017

Link zum Volltext

Verfügbarkeit prüfen

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

Nature medicine, 2006-10, Vol.12 (10), p.1160-1166

2006

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (7), p.1621-1631

2012

Link zum Volltext

Verfügbarkeit prüfen

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003237

2021

Link zum Volltext

Verfügbarkeit prüfen

Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing

Cytotherapy (Oxford, England), 2024-03, Vol.26 (3), p.266-275

2024

Link zum Volltext

Verfügbarkeit prüfen

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Blood, 2007-10, Vol.110 (8), p.2838-2845

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the Cellular Immune Response to Parainfluenza Virus 3

The Journal of infectious diseases, 2017-07, Vol.216 (2), p.153-161

2017

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies

Journal of immunotherapy (1997), 2013-01, Vol.36 (1), p.66

2013

Link zum Volltext

Verfügbarkeit prüfen

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

Journal of immunotherapy (1997), 2012-02, Vol.35 (2), p.159

2012

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector

Gene therapy, 2015-01, Vol.22 (1), p.87-95

2015

Link zum Volltext

Verfügbarkeit prüfen

Adenoviral Infections in Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2006-03, Vol.12 (3), p.243-251

2006

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immunotherapy for posttransplantation viral infections

Biology of blood and marrow transplantation, 2004-03, Vol.10 (3), p.143-155

2004

Link zum Volltext

Verfügbarkeit prüfen

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

Biology of blood and marrow transplantation, 2015-07, Vol.21 (7), p.1284-1290

2015

Link zum Volltext

Verfügbarkeit prüfen

Episodic Vestibular Symptoms in Children With a Congenital Cytomegalovirus Infection: A Case Series

Otology & neurotology, 2019-07, Vol.40 (6), p.e636

2019

Link zum Volltext

Verfügbarkeit prüfen

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

The Lancet (British edition), 2019-07, Vol.394 (10193), p.148-158

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Characterizing the Cellular Immune Response to Parainfluenza Virus 3

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector

Adenoviral Infections in Hematopoietic Stem Cell Transplantation

Adoptive immunotherapy for posttransplantation viral infections

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

Episodic Vestibular Symptoms in Children With a Congenital Cytomegalovirus Infection: A Case Series

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Aktive Filter

Suchergebnisse filtern